about
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravisEaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.Use of intravenous gamma globulins in neuroimmunologic diseases.Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and ElectrodiagnostiPractice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular anSafety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline.Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiency.A genome-wide association study of myasthenia gravisEvaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review).Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.Pearls & Oy-sters: clues to the diagnosis of adult-onset acid maltase deficiency.The paradox of muscle hypertrophy in muscular dystrophy.Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.Late-onset Becker muscular dystrophy: Refining the clinical features and electrophysiological findings.On-line analysis of neuromuscular bioelectric potentials.Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.Acetylcholine receptor-specific CD4+ T cells in myasthenia gravis patients have individual, but restricted TCR V beta usage.TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.Myokymia and neuromyotonia in a cat.Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.Th1 cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor alpha subunit.T cell recognition of the acetylcholine receptor in myasthenia gravis.The effect of sacral neuromodulation on pudendal nerve function and female sexual function.QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.Marked clinical and jitter improvement after eculizumab in refractory myasthenia.Correlation between MG-ADL and QMG assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 REGAIN study.Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisAAEE minimonograph #25: Single-fiber electromyography in myasthenia gravisImmediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravisOne hundred consecutive thymectomies for myasthenia gravis3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravisIntercostal muscle biopsy studies in myasthenia gravis: clinical correlations and the direct effects of drugs and myasthenic serumT cell recognition of muscle acetylcholine receptor in ocular myasthenia gravisTCR-Vbeta usage in the thymus and blood of myasthenia gravis patients
P50
Q30276605-7CAA3975-2335-4C50-91A7-BDE0486400AAQ30443127-CD908FD9-44DC-480F-92EF-F996FF6E592CQ34391200-F030C1D4-9E35-4C90-90A3-E7F8CB7C52F3Q34610163-27A4EBB5-746D-49FF-A311-24CD43913575Q34610169-54BC2642-575B-42D1-8704-7E6C8E7CFE3BQ35754170-5A199962-C3E2-488C-936D-CDE81545DBBBQ36004693-E3F0D211-3980-421F-AD13-F97C09E01B32Q36074105-268C93A6-15AE-4BC6-8357-8C1395A5DE4BQ36754246-A7959755-0908-4668-9B9C-E045FA9E8B8AQ36869250-CA52154D-E0B1-4488-A637-D078D72CEE30Q37351838-42E772AF-94ED-44E2-8203-464CC39E8BD4Q37548291-02B54E34-E364-4958-85D9-0F98AD865CECQ37623192-11BC65F7-985D-4B6E-8686-F8ED9DFC718BQ37975319-B60DE9A4-ABA8-43DC-B533-91E40975C61BQ38372339-594BC5A2-7F7D-4B69-92BB-7C780008B2D5Q38548042-91551EDF-4B64-4DCD-9A20-ED92269B4B79Q39354263-E230F642-626B-49BC-8967-0A33FAC00255Q40523224-974B08E8-2586-4053-85FB-50AC7169FD42Q41024195-86C171D1-DAB3-445C-ACB7-17D97EA7C4C1Q41117699-51241775-D830-4EF1-8242-725E16769A38Q41547123-44683313-DB99-467C-8AF2-34BD78BA6165Q43763423-F442F072-6076-4465-BFF2-81D8AF38F475Q44864030-58934717-1754-4487-B6DF-51B671C7B72AQ45023480-A07C8B14-0AEB-408B-AB11-C615F850DE0EQ45281605-F36CC372-9032-421C-A57F-388D0931A058Q47826905-154A052C-B3F9-47D3-84E6-0DD8A2FFF88BQ47826949-250D28D9-73FC-4657-B07A-CC3F27C956E0Q48083498-F6C6AB19-92C5-46DB-B422-81F0A368B4B8Q48120946-FF114ABA-0068-4124-9CC1-077CA597FB1DQ48172896-520C41D4-FCFA-4F43-824B-83E120DF329FQ48220847-8E53DED3-5C9D-4CC4-BA17-2FA2D23D2089Q52569924-660A34A1-9F62-400E-9488-B842CD15D9AFQ66724826-9878D148-D7CD-4BA0-8B4C-65BE1A5D0895Q69670960-75993449-A1FB-4DA9-9515-F9D56F57691DQ70053516-D80A9B6E-D5FE-4FBF-B87A-8D4DCF128C75Q71183191-9D953BB8-CB49-4671-9346-639764129195Q72893489-076B0306-1317-4872-9369-B459754ABAF2Q72928422-6831EF60-6A91-4AC3-AD98-438272D48F29Q74016803-342A4AAB-AB65-4CC4-86E0-58B9751D96F2Q77759658-9D4EC6B7-DE39-4EB5-B910-A81013564BD8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James F. Howard
@ast
James F. Howard
@en
James F. Howard
@es
James F. Howard
@nl
James F. Howard
@sl
جيمس إف. هوارد
@ar
type
label
James F. Howard
@ast
James F. Howard
@en
James F. Howard
@es
James F. Howard
@nl
James F. Howard
@sl
جيمس إف. هوارد
@ar
altLabel
Chip Howard
@en
prefLabel
James F. Howard
@ast
James F. Howard
@en
James F. Howard
@es
James F. Howard
@nl
James F. Howard
@sl
جيمس إف. هوارد
@ar
P106
P1153
35499294100
P21
P31
P3835
james-f-howard
P496
0000-0002-7136-8617